荻原広一郎 (Koichiro Ogihara) - マイポータル

基本情報

所属: 慶應義塾大学医学部泌尿器科学教室共同研究員

学位: 博士(2020年3月慶應義塾大学)

J-GLOBAL ID: 202001018089900371
researchmap会員ID: R000010525

学歴

2016年4月 - 2020年3月

慶應義塾大学, 医学研究科
2003年4月 - 2009年3月

慶應義塾大学, 医学部

論文

Potential therapeutic effects of adjuvant chemotherapy after neoadjuvant chemotherapy for locally advanced muscle-invasive bladder cancer.

Minami Omura, Eiji Kikuchi, Keisuke Shigeta, Koichiro Ogihara, Kyohei Hakozaki, Satoshi Hara, Suguru Shirotake, Hiroki Ide, Shunsuke Yoshimine, Takashi Ohigashi …

Japanese journal of clinical oncology 52(4) 388-396 2022年4月6日
Urinary pH is an independent predictor of upper tract recurrence in non-muscle-invasive bladder cancer patients with a smoking history

Hiroki Ide, Eiji Kikuchi, Koichiro Ogihara, Naoya Niwa, Keisuke Shigeta, Tsukasa Masuda, Yuto Baba, Ryuichi Mizuno, Mototsugu Oya

Scientific Reports 11(1) 2021年12月
Oncological outcomes of dose reductions in cisplatin due to renal dysfunction for patients with metastatic urothelial carcinoma

Tetsushi Murakami, Eiji Kikuchi, Hiroki Ide, Yuta Umezawa, Takayuki Takahashi, Mizuki Izawa, Kyohei Hakozaki, Keisuke Shigeta, Koichiro Ogihara, Hiroaki Kobayashi …

BJUI Compass 2(5) 322-330 2021年9月
ASO Author Reflections: Previous History of Non-urothelial Malignancy May Provide Predictive Information of Worse Clinical Outcome for Initially Diagnosed Non-Muscle Invasive Bladder Cancer.

Ryohei Kufukihara, Eiji Kikuchi, Koichiro Ogihara, Keisuke Shigeta, Mototsugu Oya

Annals of surgical oncology 28(9) 5360-5361 2021年9月
Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer.

Yuto Baba, Eiji Kikuchi, Keisuke Shigeta, Koichiro Ogihara, Masashi Matsushima, Yui Nishimoto, Yasuaki Murata, Hirotaka Asakura, Masafumi Oyama, Ryuichi Mizuno …

International journal of clinical oncology 26(11) 2094-2103 2021年8月6日
Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study

Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, Tetsushi Murakami, Tadatsugu Anno, Kota Umeda, Mizuki Izawa, Yuto Baba, Tansei Sanjo, Kazunori Shojo …

Urologic Oncology: Seminars and Original Investigations 2021年8月
Diagnostic performance of the vesical imaging-reporting and data system for detecting muscle-invasive bladder cancer in real clinical settings: Comparison with diagnostic cystoscopy.

Ryohei Kufukihara, Eiji Kikuchi, Keisuke Shigeta, Koichiro Ogihara, Yuki Arita, Hirotaka Akita, Tatsuya Suzuki, Takayuki Abe, Ryuichi Mizuno, Masahiro Jinzaki …

Urologic oncology 40(2) 61.e1-61.e8 2021年7月28日
Site-specific differences in survival among upper and lower tract urothelial carcinoma patients treated with radical surgery.

Tadatsugu Anno, Eiji Kikuchi, Keisuke Shigeta, Koichiro Ogihara, Keitaro Watanabe, Yoshinori Yanai, Kimiharu Takamatsu, Shintaro Hasegawa, Takeshi Masuda, Masafumi Oyama …

Japanese journal of clinical oncology 51(6) 984-991 2021年5月28日
Guideline adherence for radical cystectomy significantly affects survival outcomes in non-muscle-invasive bladder cancer patients

Emina Kayama, Keisuke Shigeta, Eiji Kikuchi, Koichiro Ogihara, Kyohei Hakozaki, Tomohiro Iwasawa, Ken Kamisawa, Kunimitsu Kanai, Hiroki Ide, Satoshi Hara …

Japanese Journal of Clinical Oncology 51(8) 1303-1312 2021年5月3日
The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.

Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, Tetsushi Murakami, Tadatsugu Anno, Kota Umeda, Mizuki Izawa, Yuto Baba, Tansei Sanjo, Kazunori Shojo …

Cancer science 112(3) 1084-1094 2021年3月
Role of Previous Malignancy History in Clinical Outcomes in Patients with Initially Diagnosed Non-Muscle Invasive Bladder Cancer

Ryohei Kufukihara, Eiji Kikuchi, Koichiro Ogihara, Keisuke Shigeta, Yoshinori Yanai, Kimiharu Takamatsu, Hiroki Ide, Masafumi Oyama, Hirotaka Asakura, Ryuichi Mizuno …

Annals of Surgical Oncology 2021年
Can random bladder biopsies be eliminated after bacillus Calmette-Guérin therapy against carcinoma in situ?

Kimiharu Takamatsu, Kazuhiro Matsumoto, Eiji Kikuchi, Koichiro Ogihara, Nozomi Hayakawa, Nobuyuki Tanaka, Toshikazu Takeda, Shinya Morita, Takeo Kosaka, Ryuichi Mizuno …

International urology and nephrology 53(3) 465-469 2020年10月6日査読有り
尿路上皮癌におけるPembrolizumab治療中の好中球リンパ球比の変化と治療効果の関連

荻原広一郎, 菊地栄次, 茂田啓介, 岡部尚志, 山下亮, 吉峰俊輔, 中澤龍斗, 松本一宏, 水野隆一, 原智 …

日本癌治療学会学術集会抄録集 58回 P-283 2020年10月
Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer.

Kyohei Hakozaki, Eiji Kikuchi, Koichiro Ogihara, Keisuke Shigeta, Takayuki Abe, Yasumasa Miyazaki, Gou Kaneko, Takahiro Maeda, Shunsuke Yoshimine, Kunimitsu Kanai …

Japanese journal of clinical oncology 51(2) 287-295 2020年9月7日査読有り
Relationship between radiation doses and erectile function deterioration in patients with localized prostate cancer treated with permanent prostate brachytherapy.

Keisuke Shigeta, Eiji Kikuchi, Masashi Matsushima, Koichiro Ogihara, Takeo Kosaka, Ryuichi Mizuno, Tomoki Tanaka, Naoyuki Shigematsu, Mototsugu Oya

International journal of urology : official journal of the Japanese Urological Association 27(12) 1087-1093 2020年9月6日査読有り
The pretreatment neutrophil-to-lymphocyte ratio is a novel biomarker for predicting clinical responses to pembrolizumab in platinum-resistant metastatic urothelial carcinoma patients.

Koichiro Ogihara, Eiji Kikuchi, Keisuke Shigeta, Takashi Okabe, Seiya Hattori, Ryo Yamashita, Shunsuke Yoshimine, Suguru Shirotake, Ryuto Nakazawa, Kazuhiro Matsumoto …

Urologic oncology 38(6) 602.e1-602.e10 2020年6月査読有り
膀胱全摘除術時pN陽性患者で術後補助化学療法が特に有効であるのはどういった症例か

渡邉佳太郎, 菊地栄次, 荻原広一郎, 箱崎恭平, 福本桂資郎, 宮崎保匡, 城武卓, 金井邦光, 原智, 小山政史 …

日本癌治療学会学術集会抄録集 57回 P100-7 2019年10月
術前化学療法施行後の筋層浸潤性膀胱癌への術後補助化学療法追加による治療効果の検証

大村美波, 菊地栄次, 荻原広一郎, 箱崎恭平, 福本桂資郎, 宮崎保匡, 城武卓, 金井邦光, 原智, 長田浩彦 …

日本癌治療学会学術集会抄録集 57回 P101-5 2019年10月
腹腔鏡下腎尿管全摘除術の功罪 T3N0M0上部尿路上皮癌における多施設予後解析研究

茂田啓介, 菊地栄次, 萩原正幸, 荻原広一郎, 安納忠嗣, 梅田浩太, 馬場優人, 三條丹星, 荘所一典, 武田利和 …

日本癌治療学会学術集会抄録集 57回 O11-4 2019年10月
Weibullモデルを用いた腎盂尿管癌における術後膀胱内再発のフォローアップ戦略の構築

茂田啓介, 菊地栄次, 荻原広一郎, 案納忠嗣, 田中伸之, 武田利和, 松本一宏, 小坂威雄, 水野隆一, 浅沼宏 …

日本癌治療学会学術集会抄録集 57回 O34-5 2019年10月

もっとみる

MISC

膀胱癌の筋層浸潤評価におけるVI-RADSと膀胱鏡検査の役割

久冨木原良平, 菊地栄次, 菊地栄次, 茂田啓介, 荻原広一郎, 有田祐起, 秋田大宇, 鈴木達也, 水野隆一, 大家基嗣 …

泌尿器画像診断・治療技術研究会プログラム・抄録 8th 2021年
PRETREATMENT ABSOLUTE MONOCYTE COUNT IS A NOVEL BIOMARKER FOR PREDICTING WORSE CLINICAL OUTCOME IN CHEMO-RESISTANT UROTHELIAL CARCINOMA PATIENTS TREATED WITH PEMBROLIZUMAB

Koichiro Ogihara, Eiji Kikuchi, Takashi Okabe, Ryo Yamashita, Shunsuke Yoshimine, Suguru Shirotake, Ryuto Nakazawa, Kazuhiro Matsumoto, Ryuichi Mizuno, Satoshi Hara …

JOURNAL OF UROLOGY 203 E741-E742 2020年4月
SULFASALAZINE COULD MODULATE THE CD44V9-XCT SYSTEM AND ENHANCE CDDP-INDUCED CYTOTOXIC EFFECTS IN METASTATIC BLADDER CANCER; A NOVEL THERAPEUTIC STRATEGY FOR METASTATIC BLADDER CANCER

Koichiro Ogihara, Eiji Kikuchi, Toshikazu Takeda, Kazuhiro Matsumoto, Hideyuki Saya, Mototsugu Oya

JOURNAL OF UROLOGY 203 E2-E2 2020年4月
SITE SPECIFIC DIFFERENCES IN SURVIVAL AMONG BLADDER, RENAL PELVIC, AND URETERAL UROTHELIAL CARCINOMA PATIENTS TREATED WITH RADICAL SURGERY

Tadatsugu Anno, Eiji Kikuchi, Koichiro Ogihara, Mototsugu Oya

JOURNAL OF UROLOGY 201(4) E720-E720 2019年4月
SIMULATING THE SURVEILLANCE DURATION OF INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY: AN INDIVIDUALIZED RISK BASED APPROACH APPLYING THE WEIBULL MODEL

Shigeta Keisuke, Eiji Kikuchi, Masayuki Hagiwara, Takayuki Abe, Koichiro Ogihara, Ryuichi Mizuno, Mototsugu Oya

JOURNAL OF UROLOGY 201(4) E717-E717 2019年4月
CD44 VARIANT 9 EXPRESSION IS A NOVEL INDICATOR FOR IDENTIFYING POOR SURVIVAL IN PATIENTS WITH INVASIVE UROTHELIAL CARCINOMA

Koichiro Ogihara, Eiji Kikuchi, Masayuki Hagiwara, Kazuhiro Matsumoto, Shuji Mikami, Hideyuki Saya, Mototsugu Oya

JOURNAL OF UROLOGY 201(4) E899-E900 2019年4月
PRETREATMENT NEUTROPHIL-TO-LYMPHOCYTE RATIO IS A NOVEL BIOMARKER FOR PREDICTING WORSE CLINICAL OUTCOME IN CHEMO-RESISTANT UROTHELIAL CARCINOMA PATIENTS TREATED WITH PEMBROLIZUMAB

Koichiro Ogihara, Eiji Kikuchi, Takashi Okabe, Seiya Hattori, Ryo Yamashita, Syunsuke Yoshimine, Suguru Shirotake, Kazuhiro Matsumoto, Ryuichi Mizuno, Satoshi Hara …

JOURNAL OF UROLOGY 201(4) E352-E352 2019年4月
THE SURVIVAL PREDICTION WITH TIME OF INTRAVESICAL RECURRENCE IN UPPER TRACT UROTHELIAL CARCINOMA

Koichiro Ogihara, Eiji Kikuchi, Keisuke Shigeta, Masayuki Hagiwara, Ryuichi Mizuno, Mototsugu Oya

JOURNAL OF UROLOGY 201(4) E716-E717 2019年4月
COULD LAPAROSCOPIC SURGERY HAVE SAME LONG-TERM ONCOLOGICAL OUTCOMES AS OPEN RADICAL NEPHROURETERECTOMY IN T3N0M0 UPPER TRACT UROTHELIAL CARCINOMA? A MULTICENTER COHORT STUDY ADJUSTED BY PROPENSITY SCORE MATCHING

Keisuke Shigeta, Eiji Kikuchi, Takayuki Abe, Masayuki Hagiwara, Koichiro Ogihara, Toshikazu Takeda, Kazuhiro Matsumoto, Ryuichi Mizuno, Masahiro Jinzaki, Mototsugu Oya

JOURNAL OF UROLOGY 201(4) E716-E716 2019年4月
癌幹細胞を標的としたスルファサラジン膀胱内注入治療の効果

荻原広一郎, 菊地栄次, 田中伸之, 小坂威雄, 佐谷秀行, 大家基嗣

日本癌学会学術総会抄録集(Web) 78th 2019年
The therapeutic effect of sulfasalazine for metastatic urothelial carcinoma targeting to cancer stem cell

Koichiro Ogihara, Eiji Kikuchi, Toshikazu Takeda, Takeo Kosaka, Hideyuki Saya, Mototsugu Oya

CANCER SCIENCE 109 979-979 2018年12月
MUC1C Oncoprotein Contributes to Acquiring Cisplatin and Gemcitabine Resistance in Urothelial Carcinoma Cells

Keisuke Shigeta, Eiji Kikuchi, Masanori Hasegawa, Koichiro Ogihara, Takeo Kosaka, Mototsugu Oya

CANCER SCIENCE 109 1192-1192 2018年12月
The establishment of new therapeutic strategy for metastatic urothelial carcinoma targeting against cancer stem cell

Koichiro Ogihara, Eiji Kikuchi, Kyohei Hakozaki, Shogo Okazaki, Masayuki Hagiwara, Toshikazu Takeda, Kazuhiro Matsumoto, Takeo Kosaka, Shuji Mikami, Hideyuki Saya …

INTERNATIONAL JOURNAL OF UROLOGY 25 332-332 2018年10月
CAN UROLOGISTS INTRODUCE THE CONCEPT OF "OLIGOMETASTASIS" FOR METASTATIC BLADDER CANCER AFTER RADICAL CYSTECTOMY?

Koichiro Ogihara, Eiji Kikuchi, Keitaro Watanabe, Ryohei Kufukihara, Yoshinori Yanai, Kimiharu Takamatsu, Kazuhiro Matsumoto, Satoshi Hara, Masafumi Oyama, Tetsuo Monma …

JOURNAL OF UROLOGY 199(4) E1043-E1043 2018年4月
COULD ADJUVANT CHEMOTHERAPY HAVE ADDITIONAL THERAPEUTIC BENEFIT IN BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY AND NEOADJUVANT CHEMOTHERAPY?

Minami Omura, Eiji Kikuchi, Koichiro Ogihara, Kyohei Hakozaki, Keishiro Fukumoto, Gou Kaneko, Yasumasa Miyazaki, Nobuyuki Tanaka, Suguru Shirotake, Kunimitsu Kanai …

JOURNAL OF UROLOGY 199(4) E530-E530 2018年4月
The effect of sulfasalazine on bladder cancer stem like cells targeting to cystine transporter

Koichiro Ogihara, Eiji Kikuchi, Masayuki Hagiwara, Takeo Kosaka, Hideyuki Saya, Mototsugu Oya

CANCER SCIENCE 109 1049-1049 2018年1月
PURIFIED PROTEIN DEPRIVATION SKIN TEST REACTION IS ASSOCIATED WITH CLINICAL OUTCOME OF PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER TREATED WITH BACILLUS-CALMETTE GUERIN

Naoya Niwa, Eiji Kikuchi, Kazuhiro Matsumoto, Koichiro Ogihara, Hiroshi Hongo, Takeo Kosaka, Ryuichi Mizuno, Akira Miyajima, Mototsugu Oya

JOURNAL OF UROLOGY 197(4) E904-E904 2017年4月
PREOPERATIVE NEUTROPHIL-TO-LYMPHOCYTE RATIO AND SMOKING HISTORY ARE INDEPENDENTLY ASSOCIATED WITH BCG RELAPSING TUMOR RECURRENCE IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS

Koichiro Ogihara, Eiji Kikuchi, Yoshinori Yanai, Kimiharu Takamatsu, Suguru Shirotake, Kazuhiro Matsumoto, Masafumi Oyama, Hirohiko Nagata, Akira Miyajima, Mototsugu Oya

JOURNAL OF UROLOGY 197(4) E904-E905 2017年4月
COULD ADJUVANT CHEMOTHERAPY HAVE THERAPEUTIC BENEFIT AFTER NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH EQUAL TO OR GREATER THAN PT3 MUSCLE INVASIVE BLADDER CANCER?

Minami Omura, Eiji Kikuchi, Koichiro Ogihara, Kyohei Hakozaki, Keishiro Fukumoto, Go Kaneko, Yasumasa Miyazaki, Nobuyuki Tanaka, Suguru Shirotake, Kunimitsu Kanai …

JOURNAL OF UROLOGY 197(4) E433-E433 2017年4月
WHO COULD BE ELIMINATED FOR RANDOM BIOPSIES AFTER BCG THERAPY IN PATIENTS WITH BLADDER CARCINOMA IN SITU?

Kimiharu Takamatsu, Eiji Kikuchi, Koichiro Ogihara, Nozomi Hayakawa, Kazuhiro Matsumoto, Ryuichi Mizuno, Akira Miyajima, Masafumi Oyama, Mototsugu Oya

JOURNAL OF UROLOGY 197(4) E171-E172 2017年4月

もっとみる

共同研究・競争的資金等の研究課題

CD44v陽性癌幹細胞モデルを基盤とした新規膀胱内注入療法の確立

日本学術振興会科学研究費助成事業若手研究 2021年4月 - 2023年3月

荻原広一郎
膀胱癌における癌幹細胞の制御を標的とした新規治療戦略の確立

日本学術振興会科学研究費助成事業若手研究(B) 若手研究(B) 2017年4月 - 2019年3月

荻原広一郎, 菊地栄次